Search

Risk of massive intraoperative hemorrhage and the difficulty to control it makes the laparoscopic treatment of giant hepatic hemangiomas (GH) a challenge for minimally invasive hepatobiliary surgeons. Symptomatic GHs of more than 20 cm (extremely giant hepatic hemangiomas) are typically treated with an open resection. There is a paucity of literature on laparoscopic resection of extremely giant hepatic hemangiomas. We describe (with video), here, the technical nuances of pure laparoscopic resection of an extremely giant hepatic hemangioma using modified port positions and the anterior approach.

Hollow sphere polymeric pigments prepared from styrene-acrylate copolymer referred to as organic opacifiers (OP) are the primary substitutes of TiO.sub.2 in water-based architectural paints. This study describes the method for the quantification of OP in water-based paints using dynamic mechanical thermal analysis (DMTA). The significance of DMTA in visualizing the glass transitions over differential scanning calorimetry (DSC) is showcased. The glass transition temperature (T.sub.g) of OP was found to be ~109°C by DSC method and ~125°C by DMTA method. The peak intensity of tan [delta] at T.sub.g of OP in paints (tan [delta].sub.2) is not affected by the curing time and linearly increases as a function of OP concentration in water-based paints, irrespective of the difference in volume solids. DMTA can efficiently quantify OP in paint film if it is [greater than or equal to]3.3% (w/w). Increasing concentration of a coalescing solvent in water-based paints has a detrimental effect on the peak intensity of tan [delta].sub.2. Two commercially available grades of OP having difference in the core-shell morphology have been studied. Internal morphology of the OP studied by scanning electron microscopy has a significant effect on the peak intensity of tan [delta].sub.2 thereby affecting its opacity performance in paints. Owing to the limited effect of curing time, volume solids and coalescing solvent on the peak intensity of tan [delta].sub.2 of paints, this method can be used for the quantification of OP in paints, as it has been validated with seven commercially available paints with known OP contents., Author(s): Ritesh A. Bhavsar [sup.1] , Venugopal B. Raghavendra [sup.1] Author Affiliations: (1) grid.464770.6, 0000 0004 1776 8649, Asian Paints Limited, R&T center, Plot No. C-3B/1, TTC Industrial Area, MIDC [...]

Identifies five types of museum accessibility: (1) physical; (2) socio-cultural; (3) economic; (4) sensory; and (5) intelligence/learning accessibility. Considers ways to coordinate museum services to ensure accessibility for potential museum patrons who are disabled. Describes various programs launched by the National Museum of Natural History in New Delhi to accomplish this goal. (WRM)

Currently, there are no guidelines or consensus recommendations on the antithrombotic management of peripheral artery disease (PAD) from an Indian perspective. In this article, we have summarized clinical practice recommendations on antithrombotic management of (i) asymptomatic chronic PAD (cPAD), (ii) symptomatic cPAD (intermittent claudication [IC] and chronic limb-threatening ischemia [CLTI]), and (iii) after revascularization (endovascular and surgical). An electronic search of the PubMed database was undertaken to identify relevant articles. Various combinations of keywords such as PAD, chronic peripheral arterial disease, asymptomatic chronic peripheral arterial disease, symptomatic chronic peripheral arterial disease, dual antiplatelet therapy, single antiplatelet therapy, dual pathway inhibition, antithrombotic, revascularization, endovascular, and surgical were used. Randomized controlled trials, case reports, practice guidelines, systematic literature reviews, and meta-analyses were screened and assessed. A roundtable meeting of experts (n = 13) was conducted to arrive at clinical practice recommendations. Experts made their decisions based on the evidence and guideline recommendations. In patients with asymptomatic cPAD and significant peripheral artery stenosis (PAS), long-term single antiplatelet therapy may be considered at the discretion of the clinician. There is no clear evidence in favor of long-term dual antiplatelet therapy in symptomatic cPAD. Experts agreed that low-dose rivaroxaban plus aspirin should be considered in patients with asymptomatic cPAD with >50% PAS and conditions such as diabetes and polyvascular disease. This combination was also suggested in patients with IC, CLTI, postendovascular (stent based/nonstent), and surgical revascularization to reduce cardiovascular and limb ischemic risk, including major amputation in the absence of high bleeding risk or other contraindications.

Alzheimer's disease (AD) is the most common and irreversible neurodegenerative disorder worldwide. While the precise mechanism behind this rapid progression and multifaceted disease remains unknown, the numerous drawbacks of the available therapies are prevalent, necessitating effective alternative treatment methods. In view of the rising demand for effective AD treatment, numerous reports have shown that tetrahydroisoquinoline (THIQ) is a valuable scaffold in various clinical medicinal molecules and has a promising potential as a therapeutic agent in treating AD due to its significant neuroprotective, anti-inflammatory, and antioxidative properties via several mechanisms that target the altered signaling pathways. Therefore, this review comprehensively outlines the potential application of THIQ derivatives in AD treatment and the challenges in imparting the action of these prospective therapeutic agents. The review emphasizes a number of THIQ derivatives, including Dauricine, jatrorrhizine, 1MeTIQ, and THICAPA, that have been incorporated in AD studies in recent years. Subsequently, a dedicated section of the review briefly discusses the emerging potential benefits of multi-target therapeutics, which lie in their ability to be integrated with alternative therapeutics. Eventually, this review elaborates on the rising challenges and future recommendations for the development of therapeutic drug agents to treat AD effectively. In essence, the valuable research insights of THIQ derivatives presented in this comprehensive review would serve as an integral reference for future studies to develop potent therapeutic drugs for AD research.

Chimeric antigen receptor-natural killer (CAR-NK) cell therapy is a novel immunotherapy targeting cancer cells via the generation of chimeric antigen receptors on NK cells which recognize specific cancer antigens. CAR-NK cell therapy is gaining attention nowadays owing to the ability of CAR-NK cells to release potent cytotoxicity against cancer cells without side effects such as cytokine release syndrome (CRS), neurotoxicity and graft-versus-host disease (GvHD). CAR-NK cells do not require antigen priming, thus enabling them to be used as “off-the-shelf” therapy. Nonetheless, CAR-NK cell therapy still possesses several challenges in eliminating cancer cells which reside in hypoxic and immunosuppressive tumor microenvironment. Therefore, this review is envisioned to explore the current advancements and limitations of CAR-NK cell therapy as well as discuss strategies to overcome the challenges faced by CAR-NK cell therapy. This review also aims to dissect the current status of clinical trials on CAR-NK cells and future recommendations for improving the effectiveness and safety of CAR-NK cell therapy.

A superhydrophobic coating, free of fluorinated and siloxane materials, has been prepared via reactive compatibilization of all organic blends of hydrophilic and hydrophobic materials. In this case, styrene acrylic emulsion and a combination of hydrophobic waxes (functional rice bran wax and functional polypropylene wax) are blended together in the presence of polycarbodiimide as the reactive compatibilizer. The effect of blending and crosslinking on surface morphology is studied by Fourier transform infrared spectroscopy analysis, microscopy analyses (SEM and AFM), contact angle, and surface energy measurements. After heat treatment and crosslinking, synergistic improvements of surface properties with a gradual trend toward superhydrophobicity are observed (water contact angle ≈144° and roll-off angle of <10°). The system is free of nanoparticles, and the desired surface morphology and microstructure is formed from the mixture of renewable (rice bran) wax and petrochemical (polypropylene) wax. These coatings are shown to have easy-cleaning as well as self-cleaning characteristics. Further, the coatings can withstand exposure to solvents as well as mechanical abrasion. [ABSTRACT FROM AUTHOR]

Heat shock protein 16-kDa (HSP 16-kDa) is essential for the survival of Mycobacterium tuberculosis (M. tuberculosis) during the latent period; hence, a peptide–MHC presentation of HSP 16-kDa could be a potential diagnostic and therapeutic target for latent tuberculosis (LTB). This study aimed to generate a TCR-like single-domain antibody (sDAb)-human IgG1 antibody and subsequently investigate its diagnostic and therapeutic potential in LTB, utilizing a model cell presenting the target peptide. A previously generated TCR-like sDAB that can bind to HSP 16-kDa was first fused to a human IgG1 Fc-receptor via a linker. The fusion product, sDAb-IgG1, was expressed with HEK293-F and was subsequently purified. Its diagnostic potential was investigated via cell-based ELISA utilizing MCF-7 cells peptide-pulsed with HSP 16-kDa peptides. Investigation into the antibody-dependent cell-mediated cytotoxicity (ADCC) of MCF-7 cells was also conducted to investigate its therapeutic potential. Finally, TCR-like sDAb-IgG1 was successfully produced transiently with HEK-293F and was purified using protein A chromatography. The generated antibody was tested using cell-based ELISA, which demonstrated the effective binding of the TCR-like sDAb-IgG1 to the 16-kDa peptide–MHC on the cell surface. The ADCC assay also showed that the antibody effectively mediated the ADCC of MCF-7 cells with the help of 16-kDa peptide–MHC. This allows us to hypothesize the possible utility of the said antibody for both diagnostics and therapeutics of latent tuberculosis after more investigations with clinical samples.

This research explores extant research on artificial intelligence (AI) and big data published in the premier Information Systems (IS) journals over a period of 26 years (1997–2022), and it uses the techniques of citation analysis, bibliographic coupling, and co-word analysis. Citation analysis results reveal IS as the most cited reference discipline, followed by general business, organization science, and marketing. Two major topical clusters have been identified — problem domain-specific AI (e.g., predictive analytics, machine learning algorithms, and text mining) and organizational-specific AI (e.g., big data capabilities, firm performance, agility, and strategy). Co-word analysis revealed a gradual shift of scholarly interest from problem-domain-specific AI toward organizational-specific AI. Using the citation data, the most influential (cited) authors, (cited) articles, journals, institutions, and countries are identified. Gaps in extant research and future research paths are discussed.